Home > Resources > Infographics > Falsified Medicines Directive – Reducing the Risk of Packaging Failure

Falsified Medicines Directive – Reducing the Risk of Packaging Failure

July 12, 2017

The FMD is due to be implemented from 09 February 2019, but in order to successfully implement the changes, companies need to be aware of the requirements and start testing their effectiveness. The new safety features will allow wholesale distributors and pharmacists to verify that the medicine is authentic, identify individual packs, and verify that the packaging has not been interfered with. Once manufacturers have met the specified requirements, they need to ensure that they are durable enough to withstand the demands of the supply chain.

Spotlight

Curium Pharma

Curium is a world-class nuclear medicine solutions provider with over 100 years of industry experience. We service over 14 million patients worldwide each year and strive to provide best-in-class products and exceptional, reliable service.

Other Infographics

Do patients actually watch all those pharma TV ads?

Infographic | January 13, 2020

Fewer than one in eight chronic-disease sufferers say they watch when a drug commercial comes on TV, according to one recent study of community users. And for the millennials among them, the percentage is even less so. That’s despite the $5.1 billion spent by biopharma on the medium in 2018. We take a look at these data points and many others from two recent studies on the media habits of patients and doctors.

COVID-19 Summary as of March 13, 2020

Infographic | April 6, 2020

Biomedtracker and Trialtrove have a total of 307 clinical trials for the treatment of COVID-19. 152 initiated trials for the treatment of COVID-19. 155 Trials have been announced but have not yet begun recruitment.

What is Adoptive Cell Therapy?

Infographic | February 5, 2020

A type of immunotherapy in which T cells are given to a patient to help the body fight diseases. In cancer therapy, T cells are usually taken from the patient’s own blood or tumor tissue, grown in large numbers in the laboratory, and then given back to the patient to help the immune system fight the cancer.

Summary of Chloroquine and Hydroxychloroquine Drug-Drug Interactions

Infographic | April 7, 2020

COVID-19 is a rapidly emerging and devastating pandemic disease. Recently, chloroquine (CQ) and hydroxychloroquine (HCQ) have been suggested for possible off-label use for patients suffering from a more severe clinical course.

Pharma Technology Focus

Infographic | June 3, 2022

Pharma Technology Focus is free to read on all devices.

Cancer Drugs Bring in Most Pharma Revenue

Infographic | February 25, 2020

Worldwide cancer drug sales are already way ahead of those of other drugs and the revenue generated by them is expected to grow even larger by 2024. This is according to a report recently released by consultancy Evaluate, which analyses trends in the pharmaceutical sector. According to Evaluate's calculations, oncology drugs reached US$123.8 billion in sales in 2018, more than double that of the next item on the list, drugs treating diabetes with US$48.5 billion dollars in sales. By 2024, cancer drug sales are expected to almost double to US$236.6 billion dollars.

Falsified Medicines Directive – Reducing the Risk of Packaging Failure